Jagsonpal Pharmaceuticals Appoints Anil Kumar Matai as Independent Director

Jagsonpal Pharmaceuticals Ltd. announced the appointment of Mr. Anil Kumar Matai as an Additional Director in the category of Non-Executive Independent Director, effective June 25, 2026, subject to shareholder approval. Mr. Matai brings over three decades of experience in the pharmaceutical and healthcare sectors, having held senior leadership positions focused on strategic growth and operational excellence. His appointment is expected to contribute to the company's growth and value creation for stakeholders. Jagsonpal Pharmaceuticals is a leading player in the Indian pharmaceutical market with a strong portfolio in Gynaecology, Orthopaedics, Dermatology, and Child-care segments.